Determination of Fragmentation Schemes and Metabolites of Fluorinated Histone Deacetylase Inhibitors for Use as Positron Emission Tomography Imaging Agents Using HPLC-MS/MS
Open Access
- 1 January 2018
- journal article
- Published by Scientific Research Publishing, Inc. in International Journal of Analytical Mass Spectrometry and Chromatography
- Vol. 06 (01), 1-19
- https://doi.org/10.4236/ijamsc.2018.61001
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer AgentsMolecules, 2015
- Histone deacetylases (HDACs) and brain functionNeuroepigenetics, 2015
- Erasers of Histone Acetylation: The Histone Deacetylase EnzymesCold Spring Harbor Perspectives in Biology, 2014
- DFT Study of Benzamide Coordination with Zinc (II)International Research Journal of Pure and Applied Chemistry, 2014
- Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau depositionAlzheimer's Research & Therapy, 2014
- Imaging epigenetic regulation by histone deacetylases in the brain using PET/MRI with 18F-FAHANeuroImage, 2013
- Prediction of Cognitive Decline by Positron Emission Tomography of Brain Amyloid and TauArchives of Neurology, 2012
- Targeting HDACs: A Promising Therapy for Alzheimer's DiseaseOxidative Medicine and Cellular Longevity, 2011
- Histone deacetylase inhibitors: discovery and development as anticancer agentsExpert Opinion on Investigational Drugs, 2005
- Epigenetic mechanisms in memory formationNature Reviews Neuroscience, 2005